Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient.
María Bonilla-MorenoMiriam TorrecillasJulia Laporte-AmargosAída González-DíazAlberto MussettiFe TubauCarlota GudiolM Angeles DomínguezSara MartíGraciela Rodríguez-SevillaCarmen ArdanuyPublished in: Antimicrobial agents and chemotherapy (2023)
Campylobacter bacteremia is an uncommon disease that mainly occurs in immunocompromised patients and is associated with antibiotic resistance, particularly in Campylobacter coli. We report a patient with persistent blood infection because of a multidrug-resistant (MDR) C. coli strain over a 3-month period. Through this period monotherapy with meropenem was associated with the development of resistance to it. Improving immunity status and a combined therapy for intestinal decolonization were useful to control persistent C. coli infection in this patient.
Keyphrases
- multidrug resistant
- gram negative
- escherichia coli
- case report
- drug resistant
- acinetobacter baumannii
- end stage renal disease
- biofilm formation
- antimicrobial resistance
- klebsiella pneumoniae
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- pseudomonas aeruginosa
- intensive care unit
- patient reported outcomes
- cystic fibrosis
- study protocol
- acute respiratory distress syndrome
- mechanical ventilation